Picture of Pan Pacific International Holdings logo

7532 — Pan Pacific International Holdings News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer CyclicalsBalancedLarge CapNeutral

Weed’s next frontier is in Asia

(The author is a Reuters Breakingviews columnist.  The opinions
expressed are his own. Refiles to add link.)
    By Thomas Shum
       HONG KONG, Dec 23 (Reuters Breakingviews) - Asia is
beginning to warm up to the use of cannabis. Thailand legalised
marijuana cultivation at home in 2022, while South Korea, Japan
and Malaysia are paving the way for pharmaceutical applications.
With the weed market estimated to be a $100 billion industry by
2026, according to research firm Prohibition Partners, regional
businesses are preparing for demand from Asian consumers. 
    The Thai decision to remove cannabis from narcotics control
lists is nominally to support its medical use, but this will
naturally ease recreational consumption, which may boost
international tourist inflows. Renewable energy firm Gunkul
Engineering  GUNKUL.BK  committed 2 billion baht ($57.6 million)
to building a new cannabis plantation and extraction facilities,
local Thai media reported. Cannabis-leaf chicken leg snacks and
cannabidiol-infused green teas made by Bangkok-listed
Srinanaporn Marketing  SNNP.BK  and Ichitan Group  ICHI.BK 
already line the shelves of local supermarkets. 
    Even Japan, known for its strict cannabis-possession laws,
allows cannabidiol, an active ingredient in cannabis that does
not get users high, commonly referred to as CBD. E-commerce
company Rakuten  4755.T  and Pan Pacific International’s
 7532.T  Don Quijote supermarkets now offer a wide range of CBD
oils and gummies. South Korea was the first country in East Asia
to legalise pharmaceutical cannabis, and Japan, Malaysia and
Taiwan are all considering similar moves. If American experience
is any guide, regulated pharmaceutical use will inevitably
trickle into the recreation market, boosting aggregate demand.
    China is a question mark. The country was scarred by its
experience with opium, which it associates with imperialism. On
the other hand, the marijuana plant grows naturally in Yunnan
province. China is also responsible for around 70% of global
hemp fibre production. Extraction of full spectrum hemp oil,
which contains CBD, is legal for export under tight scrutiny,
notes Andy Li, founder of Yunnan-based Hempson. Given
conservative attitudes in Beijing, Chinese recreational and
medical use of cannabis will probably occur in neighbouring
countries.
    Weed enthusiasts should be optimistic, though. Conor O’
Brien, former lead analyst at Prohibition Partners, thinks the
Asian market will grow at least 10 times to roughly $120 million
by 2026. That’s only a fraction of the $100 billion industry
that the devil’s lettuce is becoming, but it’s a start. Cannabis
in Asia will burn slowly, but where there is smoke there may
eventually be fire. 
    Follow @t__shum on Twitter
    (This is a Breakingviews prediction for 2023. To see more of
our predictions, click here.)
 (Editing by Pete Sweeney and Katrina Hamlin)
 ((For previous columns by the author, Reuters customers can
click on  SHUM/ 
SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS https://bit.ly/BVsubscribe
 | thomas.shum@thomsonreuters.com; Reuters Messaging:
thomas.shum.thomsonreuters.com@reuters.net))

Recent news on Pan Pacific International Holdings

See all news